◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

Kane Biotech Inc.

Financial Statements (IFRS) · Amounts in CAD
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024
Total Revenue 8,499 27,997 412,513 125,858 1.3M
Operating Revenue 8,499 27,997 412,513 125,858 1.3M
Cost Of Revenue 13,627 73,523 370,066 213,063 723,944
Gross Profit -5,128 -45,526 42,447 -87,205 558,754
Selling General And Administration 378,668 139,703 942,486 325,957 986,824
General And Administrative Expense 378,668 139,703 942,486 325,957 986,824
Research And Development 159,638 90,227 261,019 607,521 183,240
Operating Expense 538,306 229,930 1.2M 933,478 1.2M
Operating Income -543,434 -275,456 -1.2M -1.0M -611,310
EBIT -535,481 -243,781 -1.2M -1.0M -608,060
Interest Expense 71,864 104,760 58,659 62,421 70,576
Interest Expense Non Operating 71,864 104,760 58,659 62,421 70,576
Interest Income 7,953 6,113 1,925 1,219 3,250
Interest Income Non Operating 7,953 6,113 1,925 1,219 3,250
Net Interest Income -63,911 -98,647 -56,734 -61,202 -67,326
Other Income Expense -- 25,562 -705.00 -1,050 -5,803
Other Non Operating Income Expenses -- 20,997 -- -- --
Gain On Sale Of Security -- 4,565 -705.00 -1,050 -5,803
Pretax Income -607,345 -348,541 -1.2M -1.1M -678,636
Tax Effect Of Unusual Items 0.00 0.00 0.00 0.00 0.00
Net Income From Continuing And Discontinued Operation -607,345 -348,541 -1.2M -1.1M -605,813
Net Income From Continuing Operation Net Minority Interest -607,345 -348,541 -1.2M 227,321 -678,636
Net Income Including Noncontrolling Interests -607,345 -348,541 -1.2M -1.1M -605,813
Minority Interests 0.00 0.00 0.00 0.00 0.00
Net Income Common Stockholders -607,345 -348,541 -1.2M -1.1M -605,813
Net Income -607,345 -348,541 -1.2M -1.1M -605,813
EBITDA -499,261 -197,456 -1.1M -956,946 -561,659
Normalized EBITDA -499,261 -202,021 -1.1M -955,896 -561,659
Reconciled Depreciation 36,220 46,325 47,852 63,568 46,401
Basic EPS 0.00 0.00 -0.01 -- -0.01
Diluted EPS 0.00 0.00 -0.01 -- -0.01
Basic Average Shares 167.3M 163.0M 150.1M -- 137.5M
Diluted Average Shares 167.3M 180.5M 150.1M -- 137.5M
Total Unusual Items -- 4,565 -705.00 -1,050 -5,803
Total Unusual Items Excluding Goodwill -- 4,565 -705.00 -1,050 -5,803
Tax Rate For Calcs 0.00 0.00 0.00 0.00 0.00
Normalized Income -607,345 -353,106 -1.2M 228,371 -678,636
Diluted NI Availto Com Stockholders -607,345 -348,541 -1.2M -1.1M -605,813
Net Income Continuous Operations -607,345 -348,541 -1.2M 227,321 -678,636
Net Income Discontinuous Operations 0.00 0.00 0.00 -1.3M 72,823
Net Non Operating Interest Income Expense -63,911 -98,647 -56,734 -61,202 -67,326
Other Gand A 378,668 139,703 942,486 325,957 986,824
Reconciled Cost Of Revenue 13,627 73,523 370,066 213,063 723,944
Total Expenses 551,933 303,453 1.6M 1.1M 1.9M
Total Operating Income As Reported -543,434 -275,456 -1.2M -1.0M -611,310
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024
Cash And Cash Equivalents 939,062 1.6M 493,584 358,813 544,377
Cash Cash Equivalents And Short Term Investments 939,062 1.6M 493,584 358,813 544,377
Accounts Receivable 131,154 79,970 134,534 13,692 343,520
Receivables 131,154 139,083 203,981 88,084 786,862
Inventory 338,997 334,550 157,588 376,034 688,372
Prepaid Assets 262,420 300,147 440,043 -- --
Other Current Assets -- -- -- 205,928 192,823
Current Assets 1.7M 2.4M 1.3M 1.0M 2.2M
Gross PPE -- 1.6M 1.7M 1.6M 1.6M
Accumulated Depreciation -- -792,382 -753,591 -718,991 -677,913
Net PPE 500,919 854,520 902,171 929,262 965,850
Goodwill And Other Intangible Assets 568,020 569,943 558,515 536,055 727,088
Other Intangible Assets -- 569,943 558,515 536,055 727,088
Total Non Current Assets 1.1M 1.4M 1.5M 1.5M 1.7M
Total Assets 2.7M 3.8M 2.8M 2.5M 3.9M
Current Debt 621,546 422,604 370,702 344,224 332,526
Current Debt And Capital Lease Obligation 621,546 543,676 489,976 461,726 448,283
Accounts Payable -- 1.0M 959,341 1.2M 699,545
Payables -- 1.4M 1.8M 1.8M 2.3M
Payables And Accrued Expenses 1.2M 1.4M 1.8M 1.8M 2.3M
Current Deferred Revenue -- -- -- 0.00 0.00
Other Current Liabilities -- -- -- 120,000 --
Current Liabilities 1.9M 2.0M 2.3M 2.4M 2.8M
Long Term Debt 1.7M 1.4M 864,483 958,238 1.0M
Long Term Debt And Capital Lease Obligation 1.7M 2.1M 1.6M 1.7M 1.8M
Long Term Capital Lease Obligation -- 693,768 724,719 755,210 785,248
Total Non Current Liabilities Net Minority Interest 1.7M 2.1M 1.6M 1.7M 1.8M
Total Liabilities Net Minority Interest 3.5M 4.0M 3.9M 4.1M 4.6M
Common Stock 27.2M 27.1M 26.0M 24.4M 24.4M
Capital Stock 27.2M 27.1M 26.0M 24.4M 24.4M
Additional Paid In Capital 8.5M 8.7M 8.5M 8.3M 8.2M
Retained Earnings -36.6M -36.0M -35.6M -34.4M -33.3M
Common Stock Equity -793,369 -234,987 -1.1M -1.6M -688,646
Stockholders Equity -793,369 -234,987 -1.1M -1.6M -688,646
Total Equity Gross Minority Interest -793,369 -234,987 -1.1M -1.6M -688,646
Minority Interest -- 0.00 0.00 0.00 0.00
Total Capitalization 882,450 1.1M -269,536 -670,999 360,162
Net Tangible Assets -1.4M -804,930 -1.7M -2.2M -1.4M
Tangible Book Value -1.4M -804,930 -1.7M -2.2M -1.4M
Working Capital -186,489 402,887 -1.0M -1.4M -547,528
Invested Capital 1.5M 1.6M 101,166 -326,775 692,688
Total Debt 2.3M 2.6M 2.1M 2.2M 2.3M
Net Debt 1.4M 178,188 741,601 943,649 836,957
Share Issued 167.3M 165.9M 154.8M 137.8M 137.5M
Ordinary Shares Number 167.3M 165.9M 154.8M 137.8M 137.5M
Assets Held For Sale Current -- -- -- 0.00 0.00
Capital Lease Obligations -- 814,840 843,993 872,712 901,005
Current Capital Lease Obligation -- 121,072 119,274 117,502 115,757
Current Deferred Liabilities -- -- -- 0.00 0.00
Dueto Related Parties Current -- -- -- 0.00 8,066
Finished Goods -- 421,587 35,587 447,678 355,299
Inventories Adjustments Allowances -- -170,430 -171,514 -203,685 -48,695
Liabilities Heldfor Sale Non Current -- -- -- 0.00 0.00
Line Of Credit -- 11,734 14,368 0.00 0.00
Machinery Furniture Equipment -- 118,508 118,508 121,817 117,327
Non Current Deferred Liabilities -- -- -- 0.00 0.00
Non Current Deferred Revenue -- -- -- 0.00 0.00
Other Current Borrowings -- 410,870 356,334 344,224 332,526
Other Equity Interest 14,505 14,505 14,505 65,767 65,767
Other Payable -- 402,533 851,382 642,126 1.6M
Other Properties -- 1.5M 1.5M 1.5M 1.5M
Other Receivables -- 59,113 69,447 74,392 443,342
Raw Materials -- 35,583 293,515 129,272 381,214
Work In Process -- 47,810 0.00 2,769 554.00
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024
Operating Cash Flow -698,216 -772,903 -1.1M -419,877 -538,125
Cash Flow From Continuing Operating Activities -698,216 -772,903 -1.1M 5.3M -538,125
Depreciation And Amortization 36,220 46,325 47,852 63,568 46,401
Depreciation Amortization Depletion 36,220 46,325 47,852 63,568 46,401
Stock Based Compensation 23,963 -238,729 144,563 141,956 140,168
Change In Working Capital -149,151 -345,323 -134,714 -4.8M -109,659
Change In Receivables 7,929 64,898 -115,897 375,955 -25,605
Change In Inventory -4,447 -176,962 218,446 312,338 39,280
Change In Payables And Accrued Expense -190,360 -373,155 -3,148 -475,374 497,241
Change In Other Working Capital -- -- -- -5.0M -594,695
Change In Other Current Assets -- -- -- -13,105 -25,880
Other Non Cash Items -266,819 82,666 57,303 14.4M -9,222
Capital Expenditure -5,612 -49,661 -44,832 -41,229 -8,459
Purchase Of PPE 0.00 -- -13,755 -4,490 -4,993
Net PPE Purchase And Sale 60,000 8,860 -13,755 -4,490 -4,993
Sale Of Business 0.00 0.00 -- 72,823 0.00
Investing Cash Flow 54,388 -40,801 -44,832 31,594 -8,459
Cash Flow From Continuing Investing Activities 54,388 -40,801 -44,832 31,594 -8,459
Issuance Of Debt 0.00 1.0M -- 0.00 0.00
Repayment Of Debt -21,353 -113,153 -154,719 -154,293 -153,873
Net Issuance Payments Of Debt -21,353 886,847 -154,719 -154,293 -153,873
Issuance Of Capital Stock 0.00 1.1M 1.5M 0.00 0.00
Net Common Stock Issuance 0.00 1.1M 1.5M 0.00 0.00
Financing Cash Flow -30,095 1.9M 1.3M 202,719 81,033
Cash Flow From Continuing Financing Activities -30,095 1.9M 1.3M 202,719 81,033
Changes In Cash -673,923 1.1M 134,771 -1.3M -465,551
Beginning Cash Position 1.6M 493,584 358,813 544,377 1.0M
End Cash Position 939,062 1.6M 493,584 358,813 544,377
Free Cash Flow -703,828 -822,564 -1.1M -461,106 -546,584
Amortization Cash Flow 7,535 7,534 8,617 22,490 5,996
Amortization Of Intangibles 7,535 7,534 8,617 22,490 5,996
Cash Dividends Paid 0.00 0.00 0.00 0.00 0.00
Cash From Discontinued Financing Activities 0.00 0.00 0.00 0.00 0.00
Cash From Discontinued Investing Activities 0.00 0.00 0.00 0.00 0.00
Cash From Discontinued Operating Activities 0.00 0.00 0.00 -9.3M 0.00
Change In Prepaid Assets 37,727 139,896 -234,115 -- --
Common Stock Issuance 0.00 1.1M 1.5M 0.00 0.00
Depreciation 28,685 38,791 39,235 41,078 40,405
Gain Loss On Investment Securities 0.00 -- -1,803 -- --
Gain Loss On Sale Of PPE 264,916 30,699 1,611 205,282 0.00
Interest Paid Cff -36,254 -12,515 -12,948 -13,374 -13,794
Long Term Debt Issuance -- -- -- 0.00 0.00
Long Term Debt Payments -21,353 -113,153 -154,719 -6.2M -153,873
Net Business Purchase And Sale 0.00 0.00 -- 72,823 0.00
Net Income From Continuing Operations -607,345 -348,541 -1.2M -1.1M -605,813
Net Intangibles Purchase And Sale -5,612 -49,661 -31,077 -36,739 -3,466
Net Long Term Debt Issuance 978,647 -113,153 -154,719 -6.2M -153,873
Net Other Financing Charges -- -27,512 -- -- --
Net Other Investing Changes -- -- -- 0.00 --
Net Short Term Debt Issuance -- 1.0M -- -- 0.00
Operating Gains Losses 264,916 30,699 -192.00 205,282 --
Other Cash Adjustment Outside Changein Cash 0.00 0.00 0.00 749,248 0.00
Proceeds From Stock Option Exercised -- -- -- 250,386 248,700
Purchase Of Intangibles -5,612 -49,661 -31,077 -36,739 -3,466
Sale Of PPE -- 8,860 -- -- --
Short Term Debt Issuance -- 1.0M -- -- 0.00
Short Term Debt Payments -- -- -- -- 0.00
NEWS
Loading news...
TRENDING
Loading...